Vyro develops oncolytic viruses designed to target CNS tumors, based on pioneering research on the oncolytic properties of the Zika Virus.

Biotechnology

Vyro Bio

Vyro Bio's headquarters in São Paulo, Brazil

The Boston office serves as a key leadership hub, focusing on strategic decision-making and organizational growth.

Boston

Hugo Cabrera

Natan Siegel

Marcia De Souza Lima

Caroline Chaul

Ernesto Goulart

Mayana Zatz

Keith Okamoto

Harry Bulstrode

Jorge Kalil

The Scientific and Medical Team at Vyro Bio focuses on advancing the development of oncolytic viruses for targeting CNS tumors. This team conducts cutting-edge research, oversees laboratory operations, and provides expert medical insights, ensuring that the company's innovative treatments are both scientifically rigorous and clinically relevant. Their collaborative efforts aim to translate pioneering research into effective therapies for patients battling brain cancers.

Scientific and Medical Team

The Leadership Team at Vyro Bio drives the strategic vision and operational execution of the company’s mission to innovate oncolytic virus therapies for CNS tumors. Comprising key executives, including the CEO and COO, the team focuses on advancing research, securing partnerships, and ensuring effective resource allocation to propel the company’s groundbreaking work in cancer treatment.

Vyro Bio

Org chart

Board & advisors

Teams

Scientific and Medical Team

Leadership Team

Offices

Vyro Bio

Org chart

Board & advisors

Teams

Scientific and Medical Team

Leadership Team

Offices

Related companies